OPTIV ANTAGE DH POWER INJECTION SYSTEM

Injector And Syringe, Angiographic

MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS

The following data is part of a premarket notification filed by Mallinckrodt Inc., Liebel-flarsheim Business with the FDA for Optiv Antage Dh Power Injection System.

Pre-market Notification Details

Device IDK042744
510k NumberK042744
Device Name:OPTIV ANTAGE DH POWER INJECTION SYSTEM
ClassificationInjector And Syringe, Angiographic
Applicant MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS 2111 EAST GALBRAITH RD. Cincinnati,  OH  45237
ContactEllis Rogers
CorrespondentEllis Rogers
MALLINCKRODT INC., LIEBEL-FLARSHEIM BUSINESS 2111 EAST GALBRAITH RD. Cincinnati,  OH  45237
Product CodeDXT  
CFR Regulation Number870.1650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-10-04
Decision Date2004-11-30
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
20746190004261 K042744 000
20746190002243 K042744 000
20746190002250 K042744 000
20746190002267 K042744 000
20746190002304 K042744 000
20746190002311 K042744 000
30746190002325 K042744 000
10746190003977 K042744 000
10746190004240 K042744 000
20746190004254 K042744 000
20746190002229 K042744 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.